网红黑料

Skip to main content

John A Ligon, MD : Research

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of John A Ligon

Research at a glance

Top areas of exploration

  • Neoplasms , 4 publications
  • Cell Line, Tumor , 2 publications
  • Bone Neoplasms , 2 publications
  • Immunocompromised Host , 2 publications

Research activity

38 publications

420 citations

Why is this important?

Active clinical trials

Tinks Trial

The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docetaxel) can improve outcomes in people with鈥

Investigator
John A Ligon
Status
Accepting Candidates
Ages
2 Years - 40 Years
Sexes
All
OMS721-HCT-002

The purpose of this study is to evaluate the safety and efficacy of narsoplimab in pediatric patients with thrombotic microangiopathies (TMA) following hematopoietic stem cell transplant (HSCT).

Investigator
John A Ligon
Status
Accepting Candidates
Ages
28 Days - 17 Years
Sexes
All

My publications

38 publications

2024

INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies鈥擡stablished Findings and Future Priorities

Transplantation and Cellular Therapy

2024

Pediatric Cancer Immunotherapy and Potential for Impact on Fertility: A Need for Evidence-Based Guidance

Transplantation and Cellular Therapy

2024

RNA aggregates harness the danger response for potent cancer immunotherapy.

Cell

2024

The role of donor type and pre鈥恡ransplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia

Pediatric Transplantation

2023

A multidisciplinary pediatric oncofertility team improves fertility preservation and counseling across 7鈥墆ears

Cancer Reports